Survey to help understand patients’ experiences with mCRPC and its treatments
Friday, 30th April 2021
Evolve Fieldwork LTD. is working with Evidera, a scientific research company, to learn about patient preferences in treatments for metastatic castration resistant prostate cancer (mCRPC).
If you are interested and eligible to take part, you would participate in a 60-minute interview so we can better understand patients’ experiences with mCRPC and its treatments. Interviews will be conducted via telephone/online and would involve completing a short online survey. The study does not involve taking any treatments; we are only interested in opinions.
As compensation for your time, you would receive an incentive of £80 for taking part in the interview.
If you are interested in more information about this study, do not hesitate to contact me or complete the link below:
No upcoming events.